An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management - Archive ouverte HAL Access content directly
Journal Articles Autoimmunity Reviews Year : 2022

An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management

(1) , (1, 2) , (1) , (3, 2) , (2, 3) , (1)
1
2
3
Not file

Dates and versions

hal-03504767 , version 1 (29-12-2021)

Identifiers

Cite

Paul Decker, Thomas Moulinet, F. Pontille, M. Cravat, Marcelo de Carvalho-Bittencourt, et al.. An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management. Autoimmunity Reviews, 2022, 21 (3), pp.103013. ⟨10.1016/j.autrev.2021.103013⟩. ⟨hal-03504767⟩
64 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More